Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.90 USD
-0.03 (-0.97%)
Updated Apr 26, 2024 02:27 PM ET
After-Market: $2.92 +0.02 (0.69%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Acasti Pharma, Inc. [ACST]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Acasti Pharma, Inc.
Industry: Medical - Generic Drugs
Research Update:Positive results from two clinical trials give hope for future commercialization
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Acasti Pharma, Inc.
Industry: Medical - Generic Drugs
New board members and clinical trial optimism highlight quarter
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Acasti Pharma, Inc.
Industry: Unclassified
Initiation of Coverage: Acasti Pharma: Looking for the Thrill with Biotech Krill
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D